Screener
Nuvation Bio NUVB Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Nuvation Bio’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-203964
| For the Three Months Ended March 31, | 2026 | 2025 |
|---|---|---|
| Purchases of marketable securities | (82,146) | (60,706) |
| Proceeds from sale of marketable securities | 38,558 | 114,960 |
| Purchases of property and equipment | (48) | (72) |
| Net cash (used in) provided by investing activities | (43,636) | 54,182 |
| Cash flow from financing activities: | ||
| Payments on borrowings | — | (534) |
| Payments on revenue interest financing agreement | (864) | — |
| Proceeds from exercises of options | 908 | 1,082 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's investing cash flow?
- Nuvation Bio (NUVB) reported investing cash flow of -$43.64M in Q1 2026.
- How has Nuvation Bio's investing cash flow changed year-over-year?
- Nuvation Bio's investing cash flow decreased by 180.5% year-over-year, from $54.18M to -$43.64M.
- What is the long-term trend for Nuvation Bio's investing cash flow?
- Over 2 years (2021 to 2024), Nuvation Bio's investing cash flow has grown at a -48.1% compound annual growth rate (CAGR), from -$454.67M to $122.7M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Nuvation Bio's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude